ARCHIVES

In Brief: Marks’ Appointment As President, Chief Executive Officer Of Memorial Sloan-Kettering, Official

This article is from The Cancer Letter archive.

Vol. 06 No. 26 | June 27, 1980

Download PDF Visit The Full Archive

Related Articles

In Brief: FDA’s Tabor To Head Biological Carcinogenesis in DCE; Steve Larson to Leave NIH for Memorial

April 29, 1988

What Would You Tell a 45-Year-Old? Waxman Asks Broder

February 4, 1994

Xeloda, Taxotere, Herceptin Combination May Benefit Invasive Breast Cancer

January 25, 2008

FDA’s Oncologic Drugs Advisory Committee recommended approval of three drugs for cancer, voted down one.

September 16, 2005

Senate Committee Approves $27 Billion for NIH, $4.6 Billion for NCI

August 2, 2002

In Brief: NCI’s Cutler Clarifies Policy On Release Of Survey Data, Tape Duplicates Will Be Available At Cost

September 6, 1974